合成路线1
该中间体在本合成路线中的序号:
(IX) Benzoylation of 2’-deoxy-2’-fluoro-2’-C-methylcytidine (I) with PhCOCl in pyridine gives the tribenzoyl fluorocytidine (II) , which by benzamide hydrolysis with AcOH at reflux gives the uridine derivative (III). Ammonolysis of the benzoate esters of protected uridine (III) with NH3 in MeOH yields the deprotected uridine (IV) , which is then coupled with isopropyl N-[chloro(phenoxy)phosphoryl]-Lalaninate (V) , optionally in the presence of 1-methylimidazole in THF or CH2Cl2 , to provide 2’-deoxy-2’-fluoro-5’-O-[(O-isopropyl-L-alanino)(phenoxy)phosphoryl]-2’-methyluridine (VI) as a diastereomeric mixture . Finally, this compound is submitted to fractional crystallization and PSI-7977 is obtained as a single diastereoisomer .
Alaninate intermediate (V) is prepared by condensation of isopropyl L-alaninate hydrochloride (VIIa) or tosylate (VIIb) with phenyl dichlorophosphate (VIII) [generated by condensation of phenol (IX) with phosphoryl chloride (X) by means of Et3N in ether ] in the presence of Et3N or 1-methylimidazole in CH2Cl2 .
Benzoylation of 2’-deoxy-2’-fluoro-2’-C-methylcytidine (I) with PhCOCl in pyridine gives the tribenzoyl fluorocytidine (II) , which by benzamide hydrolysis with AcOH at reflux gives the uridine derivative (III). Ammonolysis of the benzoate esters of protected uridine (III) with NH3 in MeOH yields the deprotected uridine (IV) , which is then coupled with isopropyl N-[chloro(phenoxy)phosphoryl]-Lalaninate (V) , optionally in the presence of 1-methylimidazole in THF or CH2Cl2 , to provide 2’-deoxy-2’-fluoro-5’-O-[(O-isopropyl-L-alanino)(phenoxy)phosphoryl]-2’-methyluridine (VI) as a diastereomeric mixture . Finally, this compound is submitted to fractional crystallization and PSI-7977 is obtained as a single diastereoisomer .
Alaninate intermediate (V) is prepared by condensation of isopropyl L-alaninate hydrochloride (VIIa) or tosylate (VIIb) with phenyl dichlorophosphate (VIII) [generated by condensation of phenol (IX) with phosphoryl chloride (X) by means of Et3N in ether ] in the presence of Et3N or 1-methylimidazole in CH2Cl2 .
Benzoylation of 2’-deoxy-2’-fluoro-2’-C-methylcytidine (I) with PhCOCl in pyridine gives the tribenzoyl fluorocytidine (II) , which by benzamide hydrolysis with AcOH at reflux gives the uridine derivative (III). Ammonolysis of the benzoate esters of protected uridine (III) with NH3 in MeOH yields the deprotected uridine (IV) , which is then coupled with isopropyl N-[chloro(phenoxy)phosphoryl]-Lalaninate (V) , optionally in the presence of 1-methylimidazole in THF or CH2Cl2 , to provide 2’-deoxy-2’-fluoro-5’-O-[(O-isopropyl-L-alanino)(phenoxy)phosphoryl]-2’-methyluridine (VI) as a diastereomeric mixture . Finally, this compound is submitted to fractional crystallization and PSI-7977 is obtained as a single diastereoisomer .
Alaninate intermediate (V) is prepared by condensation of isopropyl L-alaninate hydrochloride (VIIa) or tosylate (VIIb) with phenyl dichlorophosphate (VIII) [generated by condensation of phenol (IX) with phosphoryl chloride (X) by means of Et3N in ether ] in the presence of Et3N or 1-methylimidazole in CH2Cl2 .
【1】
Sofia, M.J., Du, J., Wang, P., Nagarathnam, D. (Pharmasset, Inc.). Nucleoside phosphoramidate prodrugs. WO 2008121634. |
【2】
Sofia, M.J. Discovery and development of 2’-F-2’-C-methyl nucleosides and nucleotides for the treatment of HCV. 240th ACS Natl Meet (Aug 22-26, Boston) 2010, Abst MEDI 259. |
【3】
Sofia, M.J, Bao, D., Chang, W. et al. Discovery of a β-D-2’-deoxy-2’-α-fluoro-2’-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. J Med Chem 2010, 53(19): 7202-18. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIIa) |
68217 |
(R)-isopropyl 2-aminopropanoate hydrochloride;isopropyl L-alaninate hydrochloride |
|
C6H13NO2.HCl |
详情 | 详情
|
(VIIb) |
68218 |
(R)-isopropyl 2-aminopropanoate 4-methylbenzenesulfonate |
|
C6H13NO2.C7H8O3S |
详情 | 详情
|
(I) |
65914 |
2'-Deoxy-2'-fluoro-2'-C-methylcytidine |
817204-33-4 |
C10H14FN3O4 |
详情 | 详情
|
(II) |
65910 |
(2'R)-N-Benzoyl-2'-deoxy-2'-fluoro-2'-methylcytidine 3',5'-dibenzoate |
817204-32-3 |
C31H26FN3O7 |
详情 | 详情
|
(III) |
68214 |
((2R,3R,4S,5R)-3-(benzoyloxy)-5-(2,4-dioxo-3,4
-dihydropyrimidin-1(2H)-yl)-4-fluoro-4-
methyltetrahydrofuran-2-yl)methyl benzoate |
|
C24H21FN2O7 |
详情 | 详情
|
(IV) |
68213 |
1-((2R,3R,4S,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione |
|
C10H13FN2O5 |
详情 | 详情
|
(V) |
68215 |
isopropyl N-[chloro(phenoxy)phosphoryl]-
Lalaninate;(2R)-isopropyl 2-((chloro(phenoxy)
phosphoryl)amino)propanoate |
|
C12H17ClNO4P |
详情 | 详情
|
(VI) |
68216 |
2’-deoxy-2’-fluoro-5’-O-[(O-
isopropyl-L-alanino)(phenoxy)phosphoryl]-2’-
methyluridine |
|
C22H29FN3O9P |
详情 | 详情
|
(VIII) |
39640 |
Phenyl dichlorophosphate;phenyl phosphorodichloridate |
770-12-7 |
C6H5Cl2O2P |
详情 | 详情
|
(IX) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(X) |
42493 |
Phosphoryl chloride; Phosphorus Oxychloride; Phosphorus (V) trichloride oxide
|
10025-87-3 |
Cl3OP |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(A) Compound can be prepared in three different ways:
1) By nitration of 2-phenoxymethanesulfonanilide (I) with nitric acid in acetic acid.
2) By condensation of 2-phenoxy-4-nitroaniline (II) with methanesulfonyl chloride in pyridine.
3) By condensation of 2-bromo-4-nitromethanesulfonanilide (III) with phenol (A) by means of KOH and pyridine in benzene.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(I) |
34063 |
N-(2-phenoxyphenyl)methanesulfonamide; 2-Phenoxymethanesulfonanilide
|
51765-51-6 |
C13H13NO3S |
详情 | 详情
|
(II) |
34064 |
4-nitro-2-phenoxyaniline; 4-nitro-2-phenoxyphenylamine
|
|
C12H10N2O3 |
详情 |
详情
|
(III) |
34065 |
N-(2-bromo-4-nitrophenyl)methanesulfonamide
|
|
C7H7BrN2O4S |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) By condensation of phenol (I) with propylene (II) at temperatures ranging from 230 C to 275 C and pressures up to 3000 atm. in an autoclave, using aluminum phenoxide as catalyst.
【1】
Napolitano, J.P.; Ecke, G.G.; Kolka, A.J.; The ortho-alkylation of phenols. J Org Chem 1956, 21, 712-713.
|
【2】
Kealy, T.J.; Coffman, D.D.; Thermal addition reactions of monocyclic phenols with ethylene. J Org Chem 1961, 26, 987-992.
|
【3】
Ecke, G.G.; Kolka, A.J.; Napolitano, J.P.; Filbey, A.H.; The ortho-alkylation of phenols. J Org Chem 1957, 22, 642-646.
|
【4】
Serradell, M.N.; Castaner, J.; Sneddon, J.M.; Blancafort, P.; Disoprofol. Drugs Fut 1982, 7, 3, 156.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
31974 |
1-propene
|
115-07-1 |
C3H6 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) 1) The reaction of phenol (I) with epichlorohydrin (II) gives 1,2-epoxy-3-phenoxypropane (III), which is treated with isopropylamine (IV) to afford 3-(isopropylamino)-1-phenoxy-2-propanol (V). Cyclization of (V) with diethyl carbonate (VI) yields 3-isopropyl-5-(phenoxymethyloxazolidin-2-one) (VII), which is chloromethylated with formaldehyde - HCl giving 3-isopropyl-5-(4-chloromethylphenoxymethyl)oxazolidin-2-one (VIII). Etherification of (VIII) with ethylene glycol monoisopropyl ether (IX) yields the corresponding ether (XI), which is finally deprotected by alkaline hydrolysis.
【1】
Harting, J.; et al.; Pharmacodynamic profile of the selective beta1-adrenoceptor antagonist bisoprolol. Arzneim-Forsch Drug Res 1986, 36, 2, 200.
|
【2】
Castaner, J.; Prous, J.; Bisoprolol fumarate. Drugs Fut 1986, 11, 10, 829.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
23932 |
2-(phenoxymethyl)oxirane; oxiranylmethyl phenyl ether
|
122-60-1 |
C9H10O2 |
详情 | 详情
|
(IV) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
(V) |
23934 |
1-(isopropylamino)-3-phenoxy-2-propanol
|
|
C12H19NO2 |
详情 |
详情
|
(VI) |
17470 |
diethyl carbonate; diethylcarbonate
|
105-58-8 |
C5H10O3 |
详情 | 详情
|
(VII) |
23936 |
3-isopropyl-5-(phenoxymethyl)-1,3-oxazolidin-2-one
|
|
C13H17NO3 |
详情 |
详情
|
(VIII) |
23937 |
5-[[4-(chloromethyl)phenoxy]methyl]-3-isopropyl-1,3-oxazolidin-2-one
|
|
C14H18ClNO3 |
详情 |
详情
|
(IX) |
23938 |
2-isopropoxy-1-ethanol
|
109-59-1 |
C5H12O2 |
详情 | 详情
|
(X) |
23939 |
5-([4-[(2-isopropoxyethoxy)methyl]phenoxy]methyl)-3-isopropyl-1,3-oxazolidin-2-one
|
|
C19H29NO5 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(IV) 3-Phenoxypyridine can be prepared by two different ways:
1) By reaction of 3-hydroxypyridine (I) with bromobenzene (II) by means of KOH and copper bronze at 150 C.
2) By reaction of 3-iodopyridine (III) with phenol (IV) by means of KOH and copper bronze at 150 C.
The monosulfate salt is prepared by treating 3-phenoxypyridine with H2SO4.
【1】
Renshaw, R.R.; Conn, R.C.; Quaternary deivation of pyridyl ethers. Onium Compound. XVI. J Am Chem Soc 1937, 59, 297-301.
|
【2】
Butler, D.E. (Pfizer Inc.); 3-Phenoxypyridine monosulfate and a method for its production. BE 0861649; DE 2755016; ES 464922; FR 2392009; GB 1559918; JP 53077068; US 4128555 .
|
【3】
Owen, R.T.; Castaner, J.; Serradell, M.N.; CI-844. Drugs Fut 1985, 10, 4, 279.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13365 |
Monobromobenzene; 1-Bromobenzene;Phenylbromide;bromobenzene |
108-86-1 |
C6H5Br |
详情 | 详情
|
(II) |
12911 |
3-Hydroxypyridine; 3-Pyridinol
|
109-00-2 |
C5H5NO |
详情 | 详情
|
(III) |
29108 |
3-iodopyridine
|
|
C5H4IN |
详情 |
详情
|
(IV) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(B) Reaction of 2-ethyloxazoline (A) with phenol (B) affords the propionamide (I). Treatment of (I) with phosgene yields the imino chloride (II), which is reacted with methylcarbazate to provide the amidrazone (III). Cyclodehydration of (III) gives the triazolone (IV). Alkylation of (IV) with 1-(3-chlorophenyl)-4-(3-chloropropyl) piperazine affords nefazodone, which is isolated as the hydrochloride salt.
【1】
Fathi, N.H.; et al.; J Heterocycl Chem 1985, 22, 10, 1121.
|
【2】
Eison, M.S.; Smith, D.W.; Madding, G.D.; Taylor, D.P.; Nefazodone Hydochloride. Drugs Fut 1987, 12, 8, 758.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(A) |
28216 |
2-ethyl-4,5-dihydro-1,3-oxazole
|
10431-98-8 |
C5H9NO |
详情 | 详情
|
(I) |
28217 |
N-(2-phenoxyethyl)propanamide
|
|
C11H15NO2 |
详情 |
详情
|
(II) |
28218 |
N-(2-phenoxyethyl)propanimidoyl chloride
|
|
C11H14ClNO |
详情 |
详情
|
(III) |
28219 |
methyl 2-[(Z)-1-[(2-phenoxyethyl)amino]propylidene]-1-hydrazinecarboxylate
|
|
C13H19N3O3 |
详情 |
详情
|
(IV) |
28220 |
5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
|
|
C12H15N3O2 |
详情 |
详情
|
(V) |
28221 |
1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine
|
39577-43-0 |
C13H18Cl2N2 |
详情 | 详情
|
(C) |
12556 |
methyl 1-hydrazinecarboxylate; methyl carbazate
|
6294-89-9 |
C2H6N2O2 |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) 1) By condensation of phenol (I) with 1-n-butoxy-2,3-epoxypropane (VII) in presence of potassium hydroxide.
2) By condensation of phenol (I) with 1-chloro-2,3-epoxypropane (II) followed either by addition of n-butanol (VI) in presence of a Lewis acid or in presence of a base (IV).
【1】
Hoffmann, H.; et al.; Procedimiento de fabricacion de sustancias medicinalmente activas y metodo de preparacion de medicamentos de accion coleretica. ES 402799; FR 2134389; GB 1393451; US 3839587 .
|
【2】
Janiak, P. St.; Febuprol. Drugs Fut 1978, 3, 3, 191.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
33456 |
1-chloro-3-phenoxy-2-propanol
|
|
C9H11ClO2 |
详情 |
详情
|
(IV) |
33457 |
sodium 1-butanolate; Sodium butoxide; Sodium n-butoxide
|
2372-45-4 |
C4H9NaO |
详情 | 详情
|
(V) |
23932 |
2-(phenoxymethyl)oxirane; oxiranylmethyl phenyl ether
|
122-60-1 |
C9H10O2 |
详情 | 详情
|
(VI) |
29766 |
butanol; n-butanol; 1-butanol
|
71-36-3 |
C4H10O |
详情 | 详情
|
(VII) |
33458 |
2-(butoxymethyl)oxirane; butyl 2-oxiranylmethyl ether
|
2426-08-6 |
C7H14O2 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) The reaction of phenol (I) with ethyl 4-chloroacetoacetate (II) by means of KOH in DMSO gives ethyl 4 phenoxyacetoacetate (III), which by treatment with NH3 is converted into ethyl 3-amino-4-phenoxycrotonate (IV). The cyclization of (IV) with propargyl aldehyde (V) in hot toluene affords ethyl 2-(phenoxymethyl)nicotinate (VI), which is cyclized again by means of polyphosphoric acid (PPA) to yield 5,11-dihydro[1]benzoxepino[3,4-b)pyridin-5-one (VII). The reduction of (VII) with NaBH4 in ethanol gives the corresponding alcohol (VIII), which is finally condensed with N,N-diethylethylene diamine (IX) by means of SOCl2 in dichloromethane.
【1】
Harakawa, H.; Kumazawa, T.; Tanaka, H.; Oijo, Y.; Shuto, K.; Ishii, A.; Nakamizo, N.; Obase, H.; Oka, T.; Synthesis and antiulcer activity of 5,11-dihydro[1. J Med Chem 1988, 31, 4, 779.
|
【2】
Kumazawa, T.; Oiji, Y.; Shuto, K.; Tanaka, H. (Kyowa Hakko Kogyo Co., Ltd.); Benzepino[3,4-b]pyridine derivs.. EP 0129879; JP 1985006690; JP 1985078985; JP 1985089419; US 4547496 .
|
【3】
Castaner, J.; Prous, J.; KW-5805. Drugs Fut 1988, 13, 11, 954.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(III) |
23542 |
ethyl 3-oxo-4-phenoxybutanoate
|
|
C12H14O4 |
详情 |
详情
|
(IV) |
23543 |
ethyl (Z)-3-amino-4-phenoxy-2-butenoate
|
|
C12H15NO3 |
详情 |
详情
|
(V) |
23544 |
propiolaldehyde
|
|
C3H2O |
详情 |
详情
|
(VI) |
23545 |
ethyl 2-(phenoxymethyl)nicotinate
|
|
C15H15NO3 |
详情 |
详情
|
(VII) |
23546 |
[1]benzoxepino[3,4-b]pyridin-5(11H)-one
|
|
C13H9NO2 |
详情 |
详情
|
(VIII) |
23547 |
5,11-dihydro[1]benzoxepino[3,4-b]pyridin-5-ol
|
|
C13H11NO2 |
详情 |
详情
|
(IX) |
23548 |
N-(5,11-dihydro[1]benzoxepino[3,4-b]pyridin-5-yl)-N-[2-(dimethylamino)ethyl]amine; N(1)-(5,11-dihydro[1]benzoxepino[3,4-b]pyridin-5-yl)-N(2),N(2)-dimethyl-1,2-ethanediamine
|
|
C17H21N3O |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) The reaction of phenol (I) with ethyl bromoacetate (II) by means of NaH in dimethoxyethane gives ethyl phenoxyacetate (III), which is condensed with dimethyl methylphosphonate (IV) by means of n-butyllithium in THF to afford dimethyl 2-oxo-3-phenoxypropylphosphonate (V). The Wittig condensation of (V) with (2'alpha-hydroxy-4'alpha-p-phenylbenzoyloxy-5'beta-ormylcyclopent-1'alpha-yl)acetic acid 1,2'-lactone (VI) by means of NaH in dimethoxyethane yields the ketonic lactone (VII), which is reduced with aluminum isopropoxide in refluxing toluene to give the hydroxy lactone (VIII). The hydrolysis of the protecting group of (VIII) with K2CO3 in methanol yields the dihydroxy lactone (IX), which is then protected with dihydropyran affording the bis(tetrahydropyranyloxy) compound (X). The reduction of the lactone group of (X) with diisobutylaluminum hydride in toluene yields the protected hemiacetal (XI), which is condensed with 4-pentinoic acid (XII) by means of LiCH3 in HMPT affording 6,9alpha-dihy-droxy-11alpha,15alpha-bistetrahydropyranyloxy-16-phenoxy-17,18,19,20-tetranorprost-4-yn-13-trans-enoic acid methyl ester (XIII) resulting from the methylation with CH2N2 of the acid intermediate.
【1】
Van Horn, A.R.; Garay, G.; Edwards, J.A. (Syntex (USA), Inc.); (dl)-16-Phenoxy- and 16-substituted phenoxy-9-keto prostatrienoic acid derivatives and processes for the production thereof. DE 2927715; EP 0008003; ES 482330; FR 2430939; GB 2025413; US 4178457 . |
【2】
Muchowski, J.M.; Fried, J.H. (Syntex (USA), Inc.); 16-Phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives. DE 2627910; ES 449162; FR 2315263; US 3985791 .
|
【3】
Blancafort, P.; Castaner, J.; Serradell, M.N.; Hillier, K.; RS-84,135. Drugs Fut 1982, 7, 11, 812.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(III) |
32040 |
ethyl 2-phenoxyacetate
|
2555-49-9 |
C10H12O3 |
详情 | 详情
|
(IV) |
13607 |
dimethyl methylphosphonate
|
756-79-6 |
C3H9O3P |
详情 | 详情
|
(V) |
32041 |
dimethyl 2-oxo-3-phenoxypropylphosphonate
|
40665-68-7 |
C11H15O5P |
详情 | 详情
|
(VI) |
32042 |
(3aR,4R,5R,6aS)-4-formyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate
|
|
C21H18O5 |
详情 |
详情
|
(VII) |
32043 |
(3aR,4R,5R,6aS)-2-oxo-4-[(E)-3-oxo-4-phenoxy-1-butenyl]hexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate
|
|
C30H26O6 |
详情 |
详情
|
(VIII) |
32044 |
(3aR,4R,5R,6aS)-4-[(E,3R)-3-hydroxy-4-phenoxy-1-butenyl]-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate
|
|
C30H28O6 |
详情 |
详情
|
(IX) |
32045 |
(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxy-4-phenoxy-1-butenyl]hexahydro-2H-cyclopenta[b]furan-2-one
|
|
C17H20O5 |
详情 |
详情
|
(X) |
32046 |
(3aR,4S,5R,6aS)-4-[(E,3R)-4-phenoxy-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-butenyl]-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]hexahydro-2H-cyclopenta[b]furan-2-one
|
|
C29H40O7 |
详情 |
详情
|
(XI) |
32047 |
(3aR,4S,5R,6aS)-4-[(E,3R)-4-phenoxy-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-butenyl]-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]hexahydro-2H-cyclopenta[b]furan-2-ol
|
|
C29H42O7 |
详情 |
详情
|
(XII) |
32048 |
4-pentynoic acid
|
6089-09-4 |
C5H6O2 |
详情 | 详情
|
(XIII) |
32049 |
methyl 6-hydroxy-7-[(1R,2S,3R,5S)-5-hydroxy-2-[(E,3R)-4-phenoxy-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-butenyl]-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]cyclopentyl]-4-heptynoate
|
|
C35H50O9 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(I) This compound has been obtained by two related ways:
1) The reaction of phenol (I) with formaldehyde gives 4-(hydroxymethyl)phenol (II), which is treated with NaCN in hot DMF to yield 2-(4-hydroxyphenyl)acetonitrile (III). The hydrolysis of (III) in refluxing ethanol/water, catalyzed by a Pt catalyst affords the corresponding acetamide (IV), which is condensed with an excess of hot epichlorohydrin (V) by means of piperidine gives 2-[4-(2-oxiranylmethoxy)phenyl]acetamide (VI). Finally, the oxirane ring of (VI) is opened with isopropylamine in methanol.
2)The condensation of acetonitrile (III) with epichlorohydrin (V) as before gives the 2-[4-(2-oxiranylmethoxy)phenyl]acetonitrile (VIII), which is treated with isopropylamine (VII) in methanol yielding 2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetonitrile (IX). Finally, this compound is hydrolyzed with refluxing ethanol/water catalyzed by a Pt catalyst as before to afford the target acetamide.
【1】
Akisanya, J.; et al.; A synthesis of atenolol using a nitrile hydration catalyst. Org Process Res Dev 1998, 2, 4, 274.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
29474 |
4-(hydroxymethyl)phenol; 4-hydroxyphenylmethanol
4-hydroxybenzenemethanol; 4-Hydroxybenzyl alcohol
|
623-05-2 |
C7H8O2 |
详情 | 详情
|
(III) |
32753 |
2-(4-hydroxyphenyl)acetonitrile; 4-Hydroxybenzyl cyanide
|
14191-95-8 |
C8H7NO |
详情 | 详情
|
(IV) |
32754 |
p-Hydroxyphenylacetamide; 2-(4-hydroxyphenyl)acetamide; 4-Hydroxybenzeneacetamide; 4-Hydroxyphenylacetamide
|
17194-82-0 |
C8H9NO2 |
详情 | 详情
|
(V) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(VI) |
32755 |
2-[4-(2-oxiranylmethoxy)phenyl]acetamide
|
|
C11H13NO3 |
详情 |
详情
|
(VII) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
(VIII) |
32756 |
2-[4-(2-oxiranylmethoxy)phenyl]acetonitrile
|
|
C11H11NO2 |
详情 |
详情
|
(IX) |
32757 |
2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetonitrile
|
|
C14H20N2O2 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(I) The reaction of uniformly 14C-labeled phenol (I) with acetylenedicarboxylic acid dimethyl ester (II) gives the adduct (III), which is reduced with ammonium formate and Pd/C to yield the 2-phenoxysuccinic acid dimethyl ester (IV). The hydrolysis of (IV) in acidic medium (HCl) affords the succinic acid derivative (V), which is cyclized by means of P2O5 to provide 4-oxo-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid (VI). The reduction of (VI) by means of Ph3SiH and TFA gives 3,4-dihydro-2H-1-benzopyran-2-carboxylic acid (VII), which is condensed with 1(R)-phenylethylamine (VIII) by means of CDI to yield the corresponding amide (IX) as a diastereomeric mixture. The reduction of (IX) by means of NaAlH2(OC2H4OMe)2 affords the secondary amine (X), also as a diastereomeric mixture, which is resolved by chromatography. The desired isomer (XI) is condensed with the butyl bromide derivative (XII) by means of NaHCO3 and KI to provide the tertiary amine (XIII), which is finally debenzylated by hydrogenation with H2 over Pd/C to furnish the target labeled Repinotan.
【1】
Seidel, D.; et al.; Synthesis of [14C]-labelled repinotan hydrochloride and its major metabolite M-6. J Label Compd Radiopharm 2002, 45, 13, 1115.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
24551 |
Dimethyl acetylenedicarboxylate; Dimethyl 2-butynedioate;Acetylenedicarboxylic acid dimethyl ester |
762-42-5 |
C6H6O4 |
详情 | 详情
|
(III) |
62010 |
dimethyl (E)-2-phenoxy-2-butenedioate
|
|
C12H12O5 |
详情 |
详情
|
(IV) |
62011 |
dimethyl 2-phenoxysuccinate
|
|
C12H14O5 |
详情 |
详情
|
(V) |
62012 |
2-phenoxysuccinic acid
|
|
C10H10O5 |
详情 |
详情
|
(VI) |
62013 |
4-oxo-2-chromanecarboxylic acid
|
|
C10H8O4 |
详情 |
详情
|
(VII) |
17037 |
2-chromanecarboxylic acid
|
|
C10H10O3 |
详情 |
详情
|
(VIII) |
10039 |
(1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine
|
3886-69-9 |
C8H11N |
详情 | 详情
|
(IX) |
17040 |
(2R)-N-[(1S)-1-phenylethyl]-3,4-dihydro-2H-chromene-2-carboxamide
|
|
C18H19NO2 |
详情 |
详情
|
(X) |
17041 |
(1S)-N-[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl]-1-phenyl-1-ethanamine; N-[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl]-N-[(1S)-1-phenylethyl]amine
|
|
C18H21NO |
详情 |
详情
|
(XI) |
62014 |
(1R)-N-[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl]-1-phenyl-1-ethanamine; N-[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl]-N-[(1R)-1-phenylethyl]amine
|
|
C18H21NO |
详情 |
详情
|
(XII) |
17043 |
2-(4-bromobutyl)-1H-1,2-benzisothiazole-1,1,3(2H)-trione
|
|
C11H12BrNO3S |
详情 |
详情
|
(XIII) |
62015 |
2-(4-{[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl][(1R)-1-phenylethyl]amino}butyl)-1H-1,2-benzisothiazole-1,1,3(2H)-trione
|
|
C29H32N2O4S |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(IX) 1) The esterification of D-penicillamine (I) with trimethylsilyl chloride and DBU in DMF gives the expected ester (II), which is cyclized with 1,2-dibromoethane by means of DBU and DIEA in DMF and protected at the amino group with Fmoc-Cl and NMM to afford 4-(9-fluorenylmethoxycarbonyl)-2,2-dimethylthiomorpholine-3(S)-carboxylic acid (III), which by treatment with O-[tert-butyl(diphenyl)silyl]hydroxylamine (TBDPSO-NH2) and EDC in dichloro-methane yields the silylated carbohydroxamic acid (IV). The removal of the Fmoc group of (IV) with diethylamine in THF affords (V), which is sulfonated with 4-(4-pyridyloxy)phenylsulfonyl chloride (VI) and NMM in dichloroethane to give the protected prinomastat (VII). Finally, this compound is desilylated with concentrated HCl in methanol. The intermediate (VI) is obtained by condensation of 4-chloropyridine (VIII) with phenol (IX) at 150 C to give 4-phenoxypyridine (X), which is then sulfonated with chlorosulfonic acid and treated with oxalyl chloride to afford the desired sulfonyl chloride (VI).
【1】
Sorbera, L.A.; Castañer, J.; Prinomastat. Drugs Fut 2000, 25, 2, 150.
|
【2】
Bender, S.L.; Melnick, M.J. (Agouron Pharmaceuticals, Inc.); Metalloproteinase inhibitors, pharmaceutical compsns. containing them and their pharmaceutical uses. US 5753653 .
|
【3】
Zook, S.E.; Dagnino, R. Jr.; Deason, M.E.; Bender, S.L.; Melnick, M.J. (Agouron Pharmaceuticals, Inc.); Metalloproteinase inhibitors, pharmaceutical compsns. containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation. EP 0874830; JP 2000502330; WO 9720824 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12567 |
(2S)-2-Amino-3-methyl-3-sulfanylbutyric acid; Penicillamine; 3-Mercapto-L-valine
|
1113-41-3 |
C5H11NO2S |
详情 | 详情
|
(II) |
32883 |
trimethylsilyl (2S)-2-amino-3-methyl-3-sulfanylbutanoate
|
|
C8H19NO2SSi |
详情 |
详情
|
(III) |
32884 |
(3S)-4-[(9H-fluoren-9-ylmethoxy)carbonyl]-2,2-dimethyl-3-thiomorpholinecarboxylic acid
|
|
C22H23NO4S |
详情 |
详情
|
(IV) |
32885 |
9H-fluoren-9-ylmethyl (3S)-3-[([[tert-butyl(diphenyl)silyl]oxy]amino)carbonyl]-2,2-dimethyl-4-thiomorpholinecarboxylate
|
|
C38H42N2O4SSi |
详情 |
详情
|
(V) |
32886 |
(3S)-N-[[tert-butyl(diphenyl)silyl]oxy]-2,2-dimethyl-3-thiomorpholinecarboxamide
|
|
C23H32N2O2SSi |
详情 |
详情
|
(VI) |
32887 |
4-(4-pyridinyloxy)benzenesulfonyl chloride
|
|
C11H8ClNO3S |
详情 |
详情
|
(VII) |
32888 |
(3S)-N-[[tert-butyl(diphenyl)silyl]oxy]-2,2-dimethyl-4-[[4-(4-pyridinyloxy)phenyl]sulfonyl]-3-thiomorpholinecarboxamide
|
|
C34H39N3O5S2Si |
详情 |
详情
|
(VIII) |
32889 |
4-chloropyridine
|
7379-35-3 |
C5H4ClN |
详情 | 详情
|
(IX) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(X) |
32890 |
4-phenoxypyridine; phenyl 4-pyridinyl ether
|
4783-86-2 |
C11H9NO |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(I) The reaction of phenol (I) with 4-oxopentanoic acid (II) by means of H2SO4 gives 4,4-bis(4-hydroxyphenyl)pentanoic acid (III), which is esterified with MeOH and H2SO4 to yield the methyl pentanoate (IV). The condensation of (IV) with 2-(chloromethyl)quinoline (V) by means of K2CO3 in DMF affords the adduct (VI), which is finally hydrolyzed with NaOH in methanol/dioxane to provide the target sodium salt.
Alternatively, the intermediate methyl pentanoate (IV) can also be obtained by direct condensation of phenol (I) with methyl 4-oxopentanoate (VII) by means of H2SO4 as before.
【1】
Gunn, D.E.; Bhatia, P.; Kolasa, T.; et al.; Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesis. J Med Chem 2000, 43, 17, 3322.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
36170 |
4-oxopentanoic acid
|
123-76-2 |
C5H8O3 |
详情 | 详情
|
(III) |
22391 |
4,4-bis(4-hydroxyphenyl)pentanoic acid
|
126-00-1 |
C17H18O4 |
详情 | 详情
|
(IV) |
22392 |
methyl 4,4-bis(4-hydroxyphenyl)pentanoate
|
|
C18H20O4 |
详情 |
详情
|
(V) |
13162 |
2-(Chloromethyl)quinoline; alpha-Chloroquinaldine
|
4377-41-7 |
C10H8ClN |
详情 | 详情
|
(VI) |
22394 |
methyl 4,4-bis[4-(2-quinolinylmethoxy)phenyl]pentanoate
|
|
C38H34N2O4 |
详情 |
详情
|
(VII) |
50960 |
Methyl levulinate
|
|
C6H10O3 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(XVI) The reaction of adipic acid monomethyl ester (XIII) with SOCl2 gives the acyl chloride (XIV), which is brominated with NBS in carbon tetrachloride to yield 5-bromo-5-(chloroformyl)pentanoic acid methyl ester (XV). The reaction of (XV) with phenol (XVI) by means of DIEA in ethyl ether affords the mixed diester (XVII), which is reduced with tri-tert-butoxylithiumaluminum hydride in THF to provide 5-bromo-5-formylpentanoic acid methyl ester (XVIII). The cyclization of (XVIII) with chiral ethanone (XIX) by means of DIEA in hot dioxane gives the methyl ester (XX) of the target compound, which is finally hydrolyzed with NaOH in ethanol/water to obtain the target acid . The intermediate chiral ethanone (XIX) has been obtained as follows: The reaction of the chiral alcohol (VIII) with 4-hydroxybenzoic acid methyl ester (XXI) under Mitsunobu conditions (DEAD, PPh3) gives the chiral ether (XXII), which is then condensed with 2-methylpyridine (XXIII) by means of LiHMDS in THF to yield the target ethanone.
【1】
Sawada, K.; Tanaka, H.; Watanabe, S.; Kuroda, A.; Okada, S. (Fujisawa Pharmaceutical Co., Ltd.); Process for the preparation of indolizine derivs.. WO 9507279 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
49223 |
(1R)-1-(4-isobutylphenyl)-1-butanol
|
|
C14H22O |
详情 |
详情
|
(XIII) |
49227 |
6-methoxy-6-oxohexanoic acid
|
|
C7H12O4 |
详情 |
详情
|
(XIV) |
49228 |
methyl 6-chloro-6-oxohexanoate
|
|
C7H11ClO3 |
详情 |
详情
|
(XV) |
49229 |
methyl 5-bromo-6-chloro-6-oxohexanoate
|
|
C7H10BrClO3 |
详情 |
详情
|
(XVI) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(XVII) |
49230 |
6-methyl 1-phenyl 2-bromohexanedioate
|
|
C13H15BrO4 |
详情 |
详情
|
(XVIII) |
49231 |
methyl 5-bromo-6-oxohexanoate
|
|
C7H11BrO3 |
详情 |
详情
|
(XIX) |
49232 |
1-(4-[[(1S)-1-(4-isobutylphenyl)butyl]oxy]phenyl)-2-(2-pyridinyl)-1-ethanone
|
|
C27H31NO2 |
详情 |
详情
|
(XX) |
49233 |
methyl 4-[1-(4-[[(1S)-1-(4-isobutylphenyl)butyl]oxy]benzoyl)-3-indolizinyl]butanoate
|
|
C34H39NO4 |
详情 |
详情
|
(XXI) |
10251 |
methyl 4-hydroxybenzoate; Methyl p-hydroxybenzoate
|
99-76-3 |
C8H8O3 |
详情 | 详情
|
(XXII) |
49234 |
methyl 4-[[(1S)-1-(4-isobutylphenyl)butyl]oxy]benzoate
|
|
C22H28O3 |
详情 |
详情
|
(XXIII) |
17590 |
2-methylpyridine; 2-picoline
|
109-06-8 |
C6H7N |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
Further coupling and deprotection cycles with N(epsilon)-Boc-lysine (I), and O-tert-butyl-tyrosine (XVIII), yielded the peptide resins (XVII) and (XIX), respectively. Then, acetylation of the free amino group of peptide resin (XIX) with Ac2O, and final deprotection and cleavage from the resin by means of moist trifluoroacetic acid, phenol and triisopropylsilane furnished the title peptide amide.
【1】
Aldrich, J.V.; Murray, T.F.; Wan, Q.; A novel acetylated analogue of dynorphin A-(1-11) amide as a kappa-opioid receptor antagonist. J Med Chem 1999, 42, 16, 3011.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(I) |
18854 |
(2S)-6-[(tert-butoxycarbonyl)amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]hexanoic acid
|
|
C26H32N2O6 |
详情 |
详情
|
(XVI) |
34772 |
|
|
C114H166N22O24S3 |
详情 |
详情
|
(XVII) |
34773 |
|
|
C125H186N24O27S3 |
详情 |
详情
|
(XVIII) |
34774 |
(2S)-2-[tert-butyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-3-(4-hydroxyphenyl)propionic acid
|
|
C28H29NO5 |
详情 |
详情
|
(XIX) |
34775 |
|
|
C138H203N25O29S3 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
Alkylation of 4-fluorothiophenol (I) with 3-chloropropanol (II) in the presence of K2CO3 in DMF provided thioether (III), which was oxidized to sulfone (IV) using Oxone(R). Fluorine displacement in (IV) with phenol and K2CO3 gave phenoxy derivative (V). Subsequent Mitsunobu condensation of (V) with thioacetic acid afforded thioacetate ester (VI), which by further hydrolysis with NaOMe furnished the target thiol.
【1】
Freskos, J.N.; Abbas, Z.S.; Decrescenzo, G.A.; Getman, D.P.; Heintz, R.M.; Mischke, B.V.; McDonald, J.J. (Pharmacia Corp.); Thiol sulfone metalloprotease inhibitors. EP 0939628; WO 9803164 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(I) |
22971 |
4-fluorobenzenethiol; 4-fluorophenylhydrosulfide; 4-Fluorothiophenol
|
371-42-6 |
C6H5FS |
详情 | 详情
|
(II) |
19490 |
3-chloro-1-propanol
|
627-30-5 |
C3H7ClO |
详情 | 详情
|
(III) |
27076 |
3-[(4-fluorophenyl)sulfanyl]-1-propanol
|
|
C9H11FOS |
详情 |
详情
|
(IV) |
27077 |
3-[(4-fluorophenyl)sulfonyl]-1-propanol
|
|
C9H11FO3S |
详情 |
详情
|
(V) |
27078 |
3-[(4-phenoxyphenyl)sulfonyl]-1-propanol
|
|
C15H16O4S |
详情 |
详情
|
(VI) |
27079 |
S-[3-[(4-phenoxyphenyl)sulfonyl]propyl] ethanethioate
|
|
C17H18O4S2 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(II) The condensation of indane-1,3-dione (I) with benzaldehyde (II) by means of piperidine in refluxing benzene gives 2-benzylideneindane-1,3-dione (II), which is treated with H2O2 and NaOH in methanol to yield the epoxide (IV). The condensation of (IV) with N-(3,4-dichlorophenyl)maleimide (V) (obtained by condensation of 3,4-dichloroaniline (VI) with maleic anhydride (VII) in diethyl ether) in refluxing benzene affords the title product as a mixture of two diastereomeric racemates that are separated by column chromatography.
【2】
Wang, Z.; Hill, J.; Finn, J.; Yu, X.Y.; Keith, D.; Gallant, P.; Wendler, P. (Cubist Pharmaceuticals, Inc.); Condensed imidazolidinones as tRNA synthetase inhibitors. WO 0018772 .
|
【1】
Hill, J.M.; Oliver, N.; Yu, X.; Wang, Z.; Finn, J.; Silverman, J.; Gallant, P.; Wendler, P.; Keith, D.; Synthesis and activity of spirocyclic tetrahydrofurans as inhibitors of phenylalanine tRNA synthetase. 41st Intersci Conf Antimicrob Agents Chemother (Dec 16 2001, Chicago) 2001, Abst F-1707. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
53530 |
1,3-Diketohydrindene; 1,3-Indandione; 1,3-Indanedione
|
606-23-5 |
C9H6O2 |
详情 | 详情
|
(II) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(III) |
53531 |
2-Benzylidene-1,3-indandione
|
n/a |
C16H10O2 |
详情 | 详情
|
(IV) |
53532 |
|
n/a |
C16H10O3 |
详情 | 详情
|
(V) |
23629 |
3,4-dichloroaniline
|
95-76-1 |
C6H5Cl2N |
详情 | 详情
|
(VI) |
11182 |
2,5-Furandione; Maleic anhydride
|
108-31-6 |
C4H2O3 |
详情 | 详情
|
(VII) |
53533 |
1-(3,4-dichlorophenyl)-1H-pyrrole-2,5-dione
|
19844-27-0 |
C10H5Cl2NO2 |
详情 | 详情
|
合成路线18
该中间体在本合成路线中的序号:
(II) The condensation of indane-1,3-dione (I) with benzaldehyde (II) by means of piperidine in refluxing benzene gives 2-benzylideneindane-1,3-dione (II), which is treated with H2O2 and NaOH in methanol to yield the epoxide (IV). The condensation of (IV) with N-(3,4-dichlorophenyl)maleimide (V) (obtained by condensation of 3,4-dichloroaniline (VI) with maleic anhydride (VII) in diethyl ether) in refluxing benzene affords the title product as a mixture of two diastereomeric racemates that are separated by column chromatography.
【2】
Wang, Z.; Hill, J.; Finn, J.; Yu, X.Y.; Keith, D.; Gallant, P.; Wendler, P. (Cubist Pharmaceuticals, Inc.); Condensed imidazolidinones as tRNA synthetase inhibitors. WO 0018772 .
|
【1】
Hill, J.M.; Oliver, N.; Yu, X.; Wang, Z.; Finn, J.; Silverman, J.; Gallant, P.; Wendler, P.; Keith, D.; Synthesis and activity of spirocyclic tetrahydrofurans as inhibitors of phenylalanine tRNA synthetase. 41st Intersci Conf Antimicrob Agents Chemother (Dec 16 2001, Chicago) 2001, Abst F-1707. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
53530 |
1,3-Diketohydrindene; 1,3-Indandione; 1,3-Indanedione
|
606-23-5 |
C9H6O2 |
详情 | 详情
|
(II) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(III) |
53531 |
2-Benzylidene-1,3-indandione
|
n/a |
C16H10O2 |
详情 | 详情
|
(IV) |
53532 |
|
n/a |
C16H10O3 |
详情 | 详情
|
(V) |
53533 |
1-(3,4-dichlorophenyl)-1H-pyrrole-2,5-dione
|
19844-27-0 |
C10H5Cl2NO2 |
详情 | 详情
|
(VI) |
23629 |
3,4-dichloroaniline
|
95-76-1 |
C6H5Cl2N |
详情 | 详情
|
(VII) |
11182 |
2,5-Furandione; Maleic anhydride
|
108-31-6 |
C4H2O3 |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(I) Condensation of phenol (I) with acetone (II) in refluxing HOAc/HCl affords diol (III), which is finally converted into the desired compound by first reaction with chlorosulfonic acid in pyridine followed by treatment with aqueous KOH.
【1】
Bushman, F.D.; Rubins, K.; Molteni, V.; Hansen, M.; Rhodes, D.; Siegel, J.S.; A new class of HIV-1 integrase inhibitors: The 3,3,3',3'-tetramethyl-1,1'-spirobi (indan)-5',5',6,6'-tetrol family. J Med Chem 2000, 43, 10, 2031.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
23199 |
2-Propanone; Acetone; beta-ketopropane; chevron acetone;propan-2-one; Dimethyl formaldehyde; Dimethyl ketone; dimethylketal; Ketone propane; Methyl ketone; Propanone; Pyroacetic acid; Pyroacetic ether |
67-64-1 |
C3H6O |
详情 | 详情
|
(III) |
45615 |
|
|
C21H24O2 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(I) Friedel-Crafts acylation of phenol (I) with nonanoyl chloride (II) in the presence of AlCl3 afforded ketone (III). Aminosulfonyl chloride (V) was prepared by decarboxylation of chlorosulfonyl isocyanate (IV) upon treatment with formic acid. Finally, condensation of the sodium phenolate of (III) with aminosulfonyl chloride (V) furnished the title sulfamate.
【1】
Ahmed, S.; et al.; Novel inhibitors of the enzyme estrone sulfatase (ES). Bioorg Med Chem Lett 2001, 11, 6, 841.
|
【2】
Ahmed, S.; James, K.; Owen, C.P.; Patel, C.K.; Synthesis and biochemical evaluation of novel and potent inhibitors of the enzyme oestrone sulphatase (ES). J Steroid Biochem Mol Biol 2002, 80, 4-5, 419.
|
【3】
Ahmed, S. (Kingston University); Sulphamate cpds.. WO 0104086 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
30296 |
nonanoyl chloride
|
764-85-2 |
C9H17ClO |
详情 | 详情
|
(III) |
50915 |
4-n-Nonanoylphenol; 4-Hydroxynonanophenone
|
14392-69-9 |
C15H22O2 |
详情 | 详情
|
(IV) |
14101 |
Chlorosulfonyl isocyanate
|
1189-71-5 |
CClNO3S |
详情 | 详情
|
(V) |
40598 |
amidosulfonoyl chloride
|
7778-42-9 |
H2ClNO2S |
详情 | 详情
|
合成路线21
该中间体在本合成路线中的序号:
(III) Treatment of N-Boc-prolinol (I) with p-toluenesulfonyl chloride and pyridine afforded tosylate (II), which was condensed with the sodium salt of phenol (III) to produce ether (IV). Acid cleavage of the Boc protecting group of (IV) then gave pyrrolidine (V). Sulfonyl chloride (VII) was prepared by chlorination of the sodium salt of 5-isatinsulfonic acid (VI) with POCl3 in tetramethylenesulfone. Acylation of pyrrolidine (V) with acid chloride (VII) gave sulfonamide (VIII). Finally, the isatin nitrogen atom was methylated employing iodomethane in the presence of K2CO3.
【1】
Lee, D.; et al.; Potent and selective nonpeptide inhibitors of caspases 3 and 7. J Med Chem 2001, 44, 12, 2015.
|
【2】
Long, S.A.; Lee, D. (SmithKline Beecham Corp.); Caspases and apoptosis. EP 1001933; JP 2001512100; WO 9906367 .
|
【3】
Lee, D.; Long, S.A.; Elliott, J.D.; Gleason, J.G. (SmithKline Beecham Corp.); Caspases and apoptosis. WO 0122966 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
49819 |
(S)-1-(tert-Butoxycarbonyl)-2-pyrrolidinenemethanol
|
|
C10H19NO3 |
详情 |
详情
|
(II) |
49813 |
tert-butyl (2S)-2-([[(4-methylphenyl)sulfonyl]oxy]methyl)-1-pyrrolidinecarboxylate
|
|
C17H25NO5S |
详情 |
详情
|
(III) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(IV) |
49814 |
tert-butyl (2S)-2-(phenoxymethyl)-1-pyrrolidinecarboxylate
|
|
C16H23NO3 |
详情 |
详情
|
(V) |
49815 |
phenyl (2S)pyrrolidinylmethyl ether; (2S)-2-(phenoxymethyl)pyrrolidine
|
|
C11H15NO |
详情 |
详情
|
(VI) |
49816 |
sodium 2,3-dioxo-5-indolinesulfonate
|
|
C8H4NNaO5S |
详情 |
详情
|
(VII) |
49817 |
2,3-dioxo-5-indolinesulfonyl chloride
|
|
C8H4ClNO4S |
详情 |
详情
|
(VIII) |
49818 |
5-[[(2S)-2-(phenoxymethyl)pyrrolidinyl]sulfonyl]-1H-indole-2,3-dione
|
|
C19H18N2O5S |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
(I) The condensation of phenol (I) with ethyl bromoacetate (II) by means of NaH in refluxing dimethoxyethane gives phenoxyacetate (III), which by condensation with dimethyl methylphosphonate (IV) by means of butyllithium in THF is converted into dimethyl 2-oxo-3-phenoxypropylphosphonate (V). The Wittig condensation of (V) with (2'alpha-hydroxy-4'alpha-p-phenylbenzoyloxy)-5'beta-formylcyclopent-1’alpha-yl)acetic acid 1,2'-lactone (VI) by means of NaH in methoxyethane affords the phenoxylactone (VII), which is reduced witl aluminium isopropoxide in refluxing toluene to yield the hydroxylactone (VIII). The hydrolysis of (VIII) with K2CO3 in methanol gives the dihydroxylactone (IX), which is protected with dihydropyran and p-toluenesulfonic acid in methylene chloride giving the bis-tetrahydropyranyloxylactone (X). The reduction of (X) with diisobutylaluminium hydride in toluene yields [2'alpha-hydroxy-4'alpha-tetrahydropyranyloxy-5'beta-(3''alpha-tetrapyranyloxy-4''-phenoxybut-1''-trans-en-1''-yl)cyclopent-1'alpha-yl]acetaldehyde 1,2-hemiacetal (XI), which is condensed with 4-pentynoate (XII) by means of methyllithium and diisopropylamine in ether to afford the acetylenic prostaglandin derivative (XIII). The acetylation of (XIII) with acetic anhydride - triethylamine and dimethylaminopyridine in methylene chloride gives the diacetoxy compound (XIV), which by treatment with Cu2I2 and methyllithium in ether is converted into the cumulenic prostaglandin (XV). The elimination of the tetrahydropyran groups with acetic acid yields the dihydroxy-acetoxy ester (XVI), which is fully hydrolyzed with K2ClO3 in MeOH affording 8R-9alpha,11alpha,15alpha-trihydroxy-16-phenoxy-17,18,19,20-tetranorprosta-4,5,13-trans-trienoic acid (XVII). Finally this compound is methylated with diazomethane in ether
【1】
Serradell, M.N.; Castaner, J.; Adaikan, P.G.; Kottegoda, S.R.; Fenprostalene. Drugs Fut 1984, 9, 11, 817.
|
【2】
Muchowski, J.M.; et al. (Syntex (USA) Inc.); US 3985791 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
10640 |
(1S,3R,4S,7S,8S,10R,13S)-7-(benzyloxy)-13-[[tert-butyl(dimethyl)silyl]oxy]-1,2,5-trihydroxy-8,12,15,15-tetramethyl-9-oxo-4-[(phenylsulfanyl)methyl]tricyclo[9.3.1.0(3,8)]pentadec-11-en-10-yl acetate
|
|
C41H58O8SSi |
详情 |
详情
|
(III) |
32040 |
ethyl 2-phenoxyacetate
|
2555-49-9 |
C10H12O3 |
详情 | 详情
|
(IV) |
13607 |
dimethyl methylphosphonate
|
756-79-6 |
C3H9O3P |
详情 | 详情
|
(V) |
32041 |
dimethyl 2-oxo-3-phenoxypropylphosphonate
|
40665-68-7 |
C11H15O5P |
详情 | 详情
|
(VI) |
32042 |
(3aR,4R,5R,6aS)-4-formyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate
|
|
C21H18O5 |
详情 |
详情
|
(VII) |
32043 |
(3aR,4R,5R,6aS)-2-oxo-4-[(E)-3-oxo-4-phenoxy-1-butenyl]hexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate
|
|
C30H26O6 |
详情 |
详情
|
(VIII) |
32044 |
(3aR,4R,5R,6aS)-4-[(E,3R)-3-hydroxy-4-phenoxy-1-butenyl]-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate
|
|
C30H28O6 |
详情 |
详情
|
(IX) |
32045 |
(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxy-4-phenoxy-1-butenyl]hexahydro-2H-cyclopenta[b]furan-2-one
|
|
C17H20O5 |
详情 |
详情
|
(X) |
32046 |
(3aR,4S,5R,6aS)-4-[(E,3R)-4-phenoxy-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-butenyl]-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]hexahydro-2H-cyclopenta[b]furan-2-one
|
|
C29H40O7 |
详情 |
详情
|
(XI) |
32047 |
(3aR,4S,5R,6aS)-4-[(E,3R)-4-phenoxy-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-butenyl]-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]hexahydro-2H-cyclopenta[b]furan-2-ol
|
|
C29H42O7 |
详情 |
详情
|
(XII) |
51633 |
methyl 4-pentynoate
|
|
C6H8O2 |
详情 |
详情
|
(XIII) |
32049 |
methyl 6-hydroxy-7-[(1R,2S,3R,5S)-5-hydroxy-2-[(E,3R)-4-phenoxy-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-butenyl]-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]cyclopentyl]-4-heptynoate
|
|
C35H50O9 |
详情 |
详情
|
(XIV) |
32050 |
methyl 6-(acetoxy)-7-[(1R,2S,3R,5S)-5-(acetoxy)-2-[(E,3R)-4-phenoxy-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-butenyl]-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]cyclopentyl]-4-heptynoate
|
|
C39H54O11 |
详情 |
详情
|
(XV) |
32051 |
methyl 7-[(1R,2S,3R,5S)-5-(acetoxy)-2-[(E,3R)-4-phenoxy-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-butenyl]-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]cyclopentyl]-4,5-heptadienoate
|
|
C37H52O9 |
详情 |
详情
|
(XVI) |
32052 |
methyl 7-[(1R,2R,3R,5S)-5-(acetoxy)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxy-1-butenyl]cyclopentyl]-4,5-heptadienoate
|
|
C25H32O7 |
详情 |
详情
|
(XVII) |
32053 |
7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-phenoxy-1-butenyl]cyclopentyl]-4,5-heptadienoic acid
|
|
C22H28O6 |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
(II) The condensation of indane-1,3-dione (I) with benzaldehyde (II) by means of piperidine in refluxing benzene gives 2-benzylideneindane-1,3-dione (II), which is treated with H2O2 and NaOH in methanol to yield the epoxide (IV). The condensation of (IV) with N-(3,4-dichlorophenyl)maleimide (V) (obtained by condensation of 3,4-dichloroaniline (VI) with maleic anhydride (VII) in diethyl ether) in refluxing benzene affords a mixture of two diastereomeric racemates from which the desired isomer (VIII) is separated by column chromatography (1-3). Finally, (VIII) is reduced with NaBH4 in methanol to provide a diastereomeric mixture from which the title product is separated by chromatography.
【1】
Hill, J.M.; Oliver, N.; Yu, X.; Wang, Z.; Finn, J.; Silverman, J.; Gallant, P.; Wendler, P.; Keith, D.; Synthesis and activity of spirocyclic tetrahydrofurans as inhibitors of phenylalanine tRNA synthetase. 41st Intersci Conf Antimicrob Agents Chemother (Dec 16 2001, Chicago) 2001, Abst F-1707. |
【2】
Wang, Z.; Hill, J.; Finn, J.; Yu, X.Y.; Keith, D.; Gallant, P.; Wendler, P. (Cubist Pharmaceuticals, Inc.); Tetracyclic heterocycles as antimicrobial agents. US 6153645; WO 0017206 .
|
【3】
Wang, Z.; Hill, J.; Finn, J.; Yu, X.Y.; Keith, D.; Gallant, P.; Wendler, P. (Cubist Pharmaceuticals, Inc.); Condensed imidazolidinones as tRNA synthetase inhibitors. WO 0018772 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
53530 |
1,3-Diketohydrindene; 1,3-Indandione; 1,3-Indanedione
|
606-23-5 |
C9H6O2 |
详情 | 详情
|
(II) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(III) |
53531 |
2-Benzylidene-1,3-indandione
|
n/a |
C16H10O2 |
详情 | 详情
|
(IV) |
53532 |
|
n/a |
C16H10O3 |
详情 | 详情
|
(V) |
53533 |
1-(3,4-dichlorophenyl)-1H-pyrrole-2,5-dione
|
19844-27-0 |
C10H5Cl2NO2 |
详情 | 详情
|
(VI) |
23629 |
3,4-dichloroaniline
|
95-76-1 |
C6H5Cl2N |
详情 | 详情
|
(VII) |
11182 |
2,5-Furandione; Maleic anhydride
|
108-31-6 |
C4H2O3 |
详情 | 详情
|
(VIII) |
53598 |
|
n/a |
C26H15Cl2NO5 |
详情 | 详情
|
合成路线24
该中间体在本合成路线中的序号:
(II) The condensation of indane-1,3-dione (I) with benzaldehyde (II) by means of piperidine in refluxing benzene gives 2-benzylideneindane-1,3-dione (III), which is treated with H2O2 and NaOH in methanol to yield the epoxide (IV). The condensation of (IV) with N-(3,4-dichlorophenyl)maleimide (V) (obtained by condensation of 3,4-dichloroaniline (VI) with maleic anhydride (VII) in diethyl ether) in refluxing benzene affords a mixture of two diastereomeric racemates from which the desired isomer (VIII) is separated by column chromatography (1-3). Finally, (VIII) is reduced with NaBH4 in methanol to provide a diastereomeric mixture from which the title product is separated by chromatography.
【1】
Hill, J.M.; Oliver, N.; Yu, X.; Wang, Z.; Finn, J.; Silverman, J.; Gallant, P.; Wendler, P.; Keith, D.; Synthesis and activity of spirocyclic tetrahydrofurans as inhibitors of phenylalanine tRNA synthetase. 41st Intersci Conf Antimicrob Agents Chemother (Dec 16 2001, Chicago) 2001, Abst F-1707. |
【2】
Wang, Z.; Hill, J.; Finn, J.; Yu, X.Y.; Keith, D.; Gallant, P.; Wendler, P. (Cubist Pharmaceuticals, Inc.); Condensed imidazolidinones as tRNA synthetase inhibitors. WO 0018772 .
|
【3】
Wang, Z.; Hill, J.; Finn, J.; Yu, X.Y.; Keith, D.; Gallant, P.; Wendler, P. (Cubist Pharmaceuticals, Inc.); Tetracyclic heterocycles as antimicrobial agents. US 6153645; WO 0017206 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
53530 |
1,3-Diketohydrindene; 1,3-Indandione; 1,3-Indanedione
|
606-23-5 |
C9H6O2 |
详情 | 详情
|
(II) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(III) |
53531 |
2-Benzylidene-1,3-indandione
|
n/a |
C16H10O2 |
详情 | 详情
|
(IV) |
53532 |
|
n/a |
C16H10O3 |
详情 | 详情
|
(V) |
53533 |
1-(3,4-dichlorophenyl)-1H-pyrrole-2,5-dione
|
19844-27-0 |
C10H5Cl2NO2 |
详情 | 详情
|
(VI) |
23629 |
3,4-dichloroaniline
|
95-76-1 |
C6H5Cl2N |
详情 | 详情
|
(VII) |
11182 |
2,5-Furandione; Maleic anhydride
|
108-31-6 |
C4H2O3 |
详情 | 详情
|
(VIII) |
53598 |
|
n/a |
C26H15Cl2NO5 |
详情 | 详情
|
合成路线25
该中间体在本合成路线中的序号:
(XII) An alternative route to the intermediate bromide (IX) has been reported. Condensation of phenol (XII) with 1,1,1-trichloro-2-methyl-2-propanol (V) led to 2-phenoxyisobutyric acid (XIII), which was further esterified by treatment with SOCl2 in EtOH to yield (XIV). Friedel-Crafts acylation of (XIV) with bromoacetyl bromide (XV) in the presence of AlCl3 provided the phenacyl bromide (XVI). The corresponding phenethyl bromide (IX) was then obtained by reduction of ketone (XVI) with triethylsilane in trifluoroacetic acid.
【1】
Hirabayashi, A.; Tamai, T.; Muranaka, H.; Tanaka, N.; Ishikawa, T.; Mukaiyama, H.; Akahane, M.; Akahane, S.; beta(3)- Adrenoceptor agonists for the treatment of frequent urination and urinary incontinence: 2-[4-(2-[[1S,2R)-2- hydroxy-2-(4- hydroxyphenyl)-1-methylethyl]ethyl) phenoxy]-2-methylpropionic acid. Bioorg Med Chem 2001, 9, 12, 3265. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
25975 |
1,1,1-trichloro-2-methyl-2-propanol
|
57-15-8 |
C4H7Cl3O |
详情 | 详情
|
(IX) |
56067 |
ethyl 2-[4-(2-bromoethyl)phenoxy]-2-methylpropanoate
|
|
C14H19BrO3 |
详情 |
详情
|
(XII) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(XIII) |
56069 |
2-methyl-2-phenoxypropanoic acid
|
|
C10H12O3 |
详情 |
详情
|
(XIV) |
56070 |
ethyl 2-methyl-2-phenoxypropanoate
|
|
C12H16O3 |
详情 |
详情
|
(XV) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(XVI) |
56071 |
ethyl 2-[4-(2-bromoacetyl)phenoxy]-2-methylpropanoate
|
|
C14H17BrO4 |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(VII) Alkylation of adenine (I) by means of (R)-propylene carbonate (II) in the presence of NaOH in hot DMF provided (R)-9-(2-hydroxypropyl)adenine (III). This was condensed with tosylate (IV) using magnesium tert-butoxide to furnish the alkoxymethylphosphonate (V). Phosphonic acid (VI) was then obtained by hydrolysis of the phosphate ester groups with bromotrimethylsilane. Monophenyl phosphonate (IX) was prepared by either coupling of acid (VI) with phenol (VII) in the presence of DCC or by previous activation of (VI) with SOCl2, and then coupling with phenoxytrimethylsilane (VIII). Further activation of (IX) with SOCl2 to give (X), followed by its condensation with L-alanine isopropyl ester (XI), yielded phosphonamide (XII) as a mixture of diastereomers. The title isomer was then isolated by several alternative procedures, including column chromatography over various supports and fractional crystallization.
【1】
Prisbe, E.J.; Lee, W.A.; Rohloff, J.C.; Becker, M.W.; Chapman, H.H.; Cihlar, T.; Eisenberg, E.J.; He, G.-X.; Kernan, M.R.; Sparacino, M.L. (Gilead Sciences Inc.); Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same. WO 0208241 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10343 |
9H-Purin-6-amine; 9H-Purin-6-ylamine; Adenine
|
73-24-5 |
C5H5N5 |
详情 | 详情
|
(II) |
19244 |
(4S)-4-methyl-1,3-dioxolan-2-one |
|
C4H6O3 |
详情 |
详情
|
(III) |
19232 |
(2S)-1-(6-amino-9H-purin-9-yl)-2-propanol |
|
C8H11N5O |
详情 |
详情
|
(IV) |
12072 |
Dibromoneopentyl glycol; 2,2-Bis(bromomethyl)-1,3-propanediol
|
3296-90-0 |
C5H10Br2O2 |
详情 | 详情
|
(V) |
19246 |
diethyl [[(1S)-2-(6-amino-9H-purin-9-yl)-1-methylethyl]oxy]methylphosphonate |
|
C13H22N5O4P |
详情 |
详情
|
(VI) |
19252 |
[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl]oxy]methylphosphonic acid
|
|
C9H14N5O4P |
详情 |
详情
|
(VII) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(VIII) |
58583 |
Trimethylsilylphenoxide; Phenoxytrimethylsilane
|
1529-17-5 |
C9H14OSi |
详情 | 详情
|
(IX) |
58584 |
phenyl hydrogen {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl]oxy}methylphosphonate
|
|
C15H18N5O4P |
详情 |
详情
|
(X) |
58585 |
phenyl {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl]oxy}methylphosphonate chloride
|
|
C15H17ClN5O3P |
详情 |
详情
|
(XI) |
58586 |
isopropyl (2S)-2-aminopropanoate
|
|
C6H13NO2 |
详情 |
详情
|
(XII) |
58587 |
isopropyl (2S)-2-{[({[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl]oxy}methyl)(phenoxy)phosphoryl]amino}propanoate
|
|
C21H29N6O5P |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(XIII) Condensation of 4-nitro-ortho-phthalonitrile (XII) with phenol (XIII) in the presence of K2CO3 in DMSO gives 4-phenoxy-ortho-phthalonitrile (XIV) , which by hydrolysis with NaOH or KOH in refluxing MeOH yields 4-phenoxyphthalic acid (I) . Dehydration of dicarboxylic acid (I) using Ac2O and AcOH at reflux provides the phthalic anhydride (XV), which is then condensed with methyl 2-isocyanoacetate (XVI) using DBU in THF to generate the oxazole derivative (XVII). Rearrangement of intermediate (XVII) with HCl in MeOH at 60 °C leads to the isoquinoline derivative (XVIII), which is partially chlorinated by means of POCl3 at 70 °C to afford the 1-chloro-isoquinoline derivative (XIX). Substitution of chlorine in intermediate (XIX) using Me3B, Pd(PPh3)4 and K2CO3 in refluxing dioxane gives methyl 4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylate (XX), which is then hydrolyzed with aqueous NaOH in refluxing EtOH to yield the carboxylic acid (IX). Coupling of carboxylic acid (IX) with methyl glycinate hydrochloride (XXI) by means of PyBOP, (i-Pr)2NH and Et3N in CH2Cl2 yields the methyl ester (XXII), which is finally hydrolyzed with aqueous NaOH in THF .
【1】
Arend, M.P., Flippin, L.A., Du, X., Ho, W.-B., Turtle, E.D., Guenzler-Pukall, V. (FibroGen, Inc.). Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin. WO 2004108681. |
【2】
Kang, X., Long, W., Zhang, J., Hu, Y., Wang, Y. (Zhejiang Beta Pharma, Inc.). Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof. EP 2734504; CN 104024227; WO 2013013609. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
67865 |
4-phenoxyphthalic acid |
|
C14H10O5 |
详情 | 详情
|
(IX) |
67872 |
4-(benzyloxy)-1-methyl-6-phenoxyisoquinoline-3-carboxylic acid |
|
C21H21NO4 |
详情 | 详情
|
(XII) |
67875 |
4-nitro-ortho-phthalonitrile |
31643-49-9 |
C8H3N3O2 |
详情 | 详情
|
(XIII) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(XIV) |
67876 |
4-phenoxy-ortho-phthalonitrile |
38791-62-7 |
C14H8N2O |
详情 | 详情
|
(XV) |
67878 |
5-phenoxyisobenzofuran-1,3-dione |
|
C14H8O4 |
详情 | 详情
|
(XVI) |
67877 |
methyl 2-isocyanoacetate |
39687-95-1 |
C4H5NO2 |
详情 | 详情
|
(XVII) |
67879 |
2-(4-(methoxycarbonyl)oxazol-5-yl)-5-phenoxybenzoic acid |
|
C18H13NO6 |
详情 | 详情
|
(XVIII) |
67880 |
methyl 4-hydroxy-1-oxo-7-phenoxy-1,2-dihydroisoquinoline-3-carboxylate |
|
C17H13NO5 |
详情 | 详情
|
(XIX) |
67881 |
methyl 1-chloro-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate |
|
C17H12ClNO4 |
详情 | 详情
|
(XX) |
67882 |
methyl 4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylate |
|
C18H15NO4 |
详情 | 详情
|
(XXI) |
67884 |
methyl glycinate hydrochloride |
5680-79-5 |
C3H7NO2.HCl |
详情 | 详情
|
(XXII) |
67883 |
methyl 2-(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxamido)acetate |
|
C20H18N2O5 |
详情 | 详情
|
合成路线28
该中间体在本合成路线中的序号:
(XIII) Condensation of 5-bromophthalide (XXIII) with phenol (XIII) by means of K2CO3, CuBr and acetylacetone in DMF gives 5-phenoxyphthalide (XXIV), which is submitted to lactone ring opening using SOCl2, Ph3PCl2, B(OMe)3 and K2CO3 in refluxing toluene to yield 2-(chloro-methyl)-4-phenoxybenzoyl chloride (XXV). Esterification of acid chloride (XXV) with MeOH at 50 °C provides the methyl ester (XXVI), which is then condensed with methyl N-tosylglycinate (XXVII) in the presence of K2CO3 and NaI in DMF at 50 °C to afford the N-substituted amino ester (XXVIII). Cyclization of diester (XXVIII) with NaOMe in MeOH leads to methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate (XXIX), which is submitted to Mannich reaction with bis(dimethylamino)methane (XXX) by means of AcOH at 57 °C to provide the 1-(dimethylaminomethyl)isoquinoline derivative (XXXI). Treatment of compound (XXXI) with Ac2O at 103 °C, followed by selective hydrolysis of the phenolic acetate with morpholine leads to methyl 1-(acetoxymethyl)-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate (XXXII). Hydrogenolysis of benzylic acetate (XXXII) in the presence of Pd/C and Na2CO3 in EtOAc yields methyl 4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboylate (XX), which is finally condensed with glycine (II) by means of NaOMe in MeOH at 110 °C .
【1】
Thompson, M.D., Park, J.M., Arend, M.P. (FibroGen, Inc.). Process for making isoquinoline compounds. CN 103435546; WO 2014014834. |
【2】
Witschi, C., Park, J.M., Thompson, M.D., Martinelli, M.J., Yeowell, D.A.,Arend, M.P. (FibroGen, Inc.). Crystalline forms of a prolyl hydroxylase inhibitor. WO 2014014835, US 2014024675. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(XIII) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(XX) |
67882 |
methyl 4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylate |
|
C18H15NO4 |
详情 | 详情
|
(XXIII) |
33229 |
5-bromophthalide; 5-bromo-2-benzofuran-1(3H)-one
|
64169-34-2 |
C8H5BrO2 |
详情 | 详情
|
(XXIV) |
67885 |
5-phenoxyphthalide |
57830-14-5 |
C14H10O3 |
详情 | 详情
|
(XXV) |
67886 |
2-(chloromethyl)-4-phenoxybenzoyl chloride |
|
C14H10Cl2O2 |
详情 | 详情
|
(XXVI) |
67887 |
methyl 2-(chloromethyl)-4-phenoxybenzoate |
|
C15H13ClO3 |
详情 | 详情
|
(XXVII) |
57744 |
methyl 2-{[(4-methylphenyl)sulfonyl]amino}acetate
|
2645-02-5 |
C10H13NO4S |
详情 | 详情
|
(XXVIII) |
67888 |
methyl 2-((N-(2-methoxy-2-oxoethyl)-4-methylphenylsulfonamido)methyl)-4-phenoxybenzoate |
|
C25H25NO7S |
详情 | 详情
|
(XXIX) |
67889 |
methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate |
|
C17H13NO4 |
详情 | 详情
|
(XXX) |
14349 |
N,N,N,N-tetramethylmethanediamine; tetramethylmethylenediamine;bis(dimethylamino)methane; N-[(dimethylamino)methyl]-N,N-dimethylamine |
51-80-9 |
C5H14N2 |
详情 | 详情
|
(XXXI) |
67890 |
methyl 1-((dimethylamino)methyl)-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate |
|
C20H20N2O4 |
详情 | 详情
|
(XXXII) |
67891 |
methyl 1-(acetoxymethyl)-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate |
|
C20H17NO6 |
详情 | 详情
|